PhRMA Report: Medicines in Development – Vaccines – A Report on the Prevention and Treatment of Disease Through Vaccines

Report: Medicines in Development – Vaccines – A Report on the Prevention and Treatment of Disease Through Vaccines
The Pharmaceutical Research and Manufacturers of America (PhRMA)
September 2013: 36 pages Link: report

PhRMA released a report which noted that America’s biopharmaceutical companies are currently developing 271 vaccines to prevent – and in some cases treat – a variety of conditions, including infectious diseases, various forms of cancer and neurological disorders. These potential vaccines – all in human clinical trials or under review by the Food and Drug Administration (FDA) – include 137 for infectious diseases, 99 for cancer, 15 for allergies and 10 for neurological disorders. The report also noted that there are 204 active clinical trials for vaccines in the U.S., including 107 that have not yet started recruiting patients or are just now seeking volunteers to participate.